Green Cross Holdings Corporation (KRX:005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,740
+190 (1.40%)
At close: Apr 25, 2025, 3:30 PM KST
-14.39%
Market Cap 631.08B
Revenue (ttm) 2.20T
Net Income (ttm) 23.78B
Shares Out 45.40M
EPS (ttm) 523.69
PE Ratio 26.54
Forward PE n/a
Dividend 500.00 (3.60%)
Ex-Dividend Date Dec 27, 2024
Volume 41,607
Average Volume 55,226
Open 13,560
Previous Close 13,550
Day's Range 13,560 - 13,750
52-Week Range 12,000 - 18,490
Beta 1.13
RSI 59.80
Earnings Date May 15, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 151
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.